182 related articles for article (PubMed ID: 10484247)
1. Cost of Alzheimer's disease and related dementia in managed-medicare.
Gutterman EM; Markowitz JS; Lewis B; Fillit H
J Am Geriatr Soc; 1999 Sep; 47(9):1065-71. PubMed ID: 10484247
[TBL] [Abstract][Full Text] [Related]
2. Alzheimer's disease and related dementias increase costs of comorbidities in managed Medicare.
Hill JW; Futterman R; Duttagupta S; Mastey V; Lloyd JR; Fillit H
Neurology; 2002 Jan; 58(1):62-70. PubMed ID: 11781407
[TBL] [Abstract][Full Text] [Related]
3. Misclassification and selection bias when identifying Alzheimer's disease solely from Medicare claims records.
Newcomer R; Clay T; Luxenberg JS; Miller RH
J Am Geriatr Soc; 1999 Feb; 47(2):215-9. PubMed ID: 9988293
[TBL] [Abstract][Full Text] [Related]
4. Alzheimer's disease under managed care: implications from Medicare utilization and expenditure patterns.
Weiner M; Powe NR; Weller WE; Shaffer TJ; Anderson GF
J Am Geriatr Soc; 1998 Jun; 46(6):762-70. PubMed ID: 9625195
[TBL] [Abstract][Full Text] [Related]
5. Impact of donepezil use in routine clinical practice on health care costs in patients with Alzheimer's disease and related dementias enrolled in a large medicare managed care plan: a case-control study.
Lu S; Hill J; Fillit H
Am J Geriatr Pharmacother; 2005 Jun; 3(2):92-102. PubMed ID: 16129386
[TBL] [Abstract][Full Text] [Related]
6. Health care utilization and costs of Alzheimer's disease: the role of co-morbid conditions, disease stage, and pharmacotherapy.
Fillit H; Hill JW; Futterman R
Fam Med; 2002; 34(7):528-35. PubMed ID: 12144008
[TBL] [Abstract][Full Text] [Related]
7. Healthcare utilization and costs in managed care patients with Alzheimer's disease during the last few years of life.
McCormick WC; Hardy J; Kukull WA; Bowen JD; Teri L; Zitzer S; Larson EB
J Am Geriatr Soc; 2001 Sep; 49(9):1156-60. PubMed ID: 11559373
[TBL] [Abstract][Full Text] [Related]
8. Health service utilization among Alzheimer's disease patients: evidence from managed care.
Frytak JR; Henk HJ; Zhao Y; Bowman L; Flynn JA; Nelson M
Alzheimers Dement; 2008 Sep; 4(5):361-7. PubMed ID: 18790463
[TBL] [Abstract][Full Text] [Related]
9. The costs of vascular dementia: a comparison with Alzheimer's disease.
Fillit H; Hill J
J Neurol Sci; 2002 Nov; 203-204():35-9. PubMed ID: 12417354
[TBL] [Abstract][Full Text] [Related]
10. The direct health care cost to Medicare of Down syndrome dementia as compared with Alzheimer's disease among 2015 Californian beneficiaries.
Bayen E; Yaffe K; Cleret de Langavant L; Chen Y; Possin KL
Ann Phys Rehabil Med; 2021 Jan; 64(1):101430. PubMed ID: 32853759
[TBL] [Abstract][Full Text] [Related]
11. Impact of dementia on costs of modifiable comorbid conditions.
Salber PR; Selecky CE; Soenksen D; Wilson T
Am J Manag Care; 2018 Nov; 24(11):e344-e351. PubMed ID: 30452202
[TBL] [Abstract][Full Text] [Related]
12. Cost of dementia in Medicare managed care: a systematic literature review.
Fishman P; Coe NB; White L; Crane PK; Park S; Ingraham B; Larson EB
Am J Manag Care; 2019 Aug; 25(8):e247-e253. PubMed ID: 31419102
[TBL] [Abstract][Full Text] [Related]
13. Prevalence, costs, and treatment of Alzheimer's disease and related dementia: a managed care perspective.
Rice DP; Fillit HM; Max W; Knopman DS; Lloyd JR; Duttagupta S
Am J Manag Care; 2001 Aug; 7(8):809-18. PubMed ID: 11519239
[TBL] [Abstract][Full Text] [Related]
14. The relationship between a dementia diagnosis, chronic illness, medicare expenditures, and hospital use.
Bynum JP; Rabins PV; Weller W; Niefeld M; Anderson GF; Wu AW
J Am Geriatr Soc; 2004 Feb; 52(2):187-94. PubMed ID: 14728626
[TBL] [Abstract][Full Text] [Related]
15. Medical services utilization and charge comparisons between elderly patients with and without Alzheimer's disease in a managed care organization.
Richards KM; Shepherd MD; Crismon ML; Snyder EH; Jermain DM
Clin Ther; 2000 Jun; 22(6):775-91. PubMed ID: 10929924
[TBL] [Abstract][Full Text] [Related]
16. Recommendations for best practices in the treatment of Alzheimer's disease in managed care.
Fillit HM; Doody RS; Binaso K; Crooks GM; Ferris SH; Farlow MR; Leifer B; Mills C; Minkoff N; Orland B; Reichman WE; Salloway S
Am J Geriatr Pharmacother; 2006; 4 Suppl A():S9-S24; quiz S25-S28. PubMed ID: 17157793
[TBL] [Abstract][Full Text] [Related]
17. Health outcomes and medicaid costs for frail older individuals: a case study of a MCO versus fee-for-service care.
Burton LC; Weiner JP; Stevens GD; Kasper J
J Am Geriatr Soc; 2002 Feb; 50(2):382-8. PubMed ID: 12028225
[TBL] [Abstract][Full Text] [Related]
18. The effect of donepezil therapy on health costs in a Medicare managed care plan.
Hill JW; Futterman R; Mastey V; Fillit H
Manag Care Interface; 2002 Mar; 15(3):63-70. PubMed ID: 11925682
[TBL] [Abstract][Full Text] [Related]
19. The clinical and economic burden of newly diagnosed Alzheimer's disease in a medicare advantage population.
Suehs BT; Davis CD; Alvir J; van Amerongen D; Pharmd NC; Joshi AV; Faison WE; Shah SN
Am J Alzheimers Dis Other Demen; 2013 Jun; 28(4):384-92. PubMed ID: 23687180
[TBL] [Abstract][Full Text] [Related]
20. The cost of Alzheimer's disease in managed care: a cross-sectional study.
Leon J; Neumann PJ
Am J Manag Care; 1999 Jul; 5(7):867-77. PubMed ID: 10557408
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
